Identification of Serratia marcescens populations of nosocomial origin by RAPD-PCR

José Antonio Enciso-Moreno1, Norma Pernas-Buitrón, Maribel Ortiz-Herrera

  • 1Laboratorio de Biología Molecular, Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, Centro Médico Nacional Siglo XXI (CMNSXXI), Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.

Abstract

Insights

Random Amplification Polymorphic DNA-PCR (RAPD-PCR) effectively identifies Serratia marcescens strains from hospital outbreaks. This method aids in understanding bacterial evolution and dissemination patterns in healthcare settings.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Serratia marcescens is an emerging pathogen in immunocompromised individuals and a cause of high-mortality nosocomial outbreaks.
  • Effective identification methods are crucial for studying the dynamics and evolution of nosocomial S. marcescens strains.

Purpose of the Study:

  • To identify S. marcescens strains from nosocomial outbreaks in pediatric hospitals using Random Amplification Polymorphic DNA-PCR (RAPD-PCR).

Main Methods:

  • RAPD-PCR was employed to analyze five S. marcescens populations from four nosocomial outbreaks in two pediatric hospitals.
  • The RAPD-PCR method was compared against the established biotyping system by Grimont and Grimont.

Main Results:

  • The combined use of biotypification and RAPD-PCR enabled precise identification of S. marcescens strains from pediatric hospital nosocomial outbreaks.
  • RAPD-PCR facilitated the analysis of clonal variations within S. marcescens populations, revealing bacterial dissemination patterns and clonal evolution under selective pressures.

Conclusions:

  • RAPD-PCR is a valuable and effective technique for identifying Serratia marcescens strains implicated in nosocomial outbreaks.